Arkema Sa Adr Stock Fundamentals
| ARKAY Stock | USD 79.24 1.06 1.36% |
Arkema SA ADR fundamentals help investors to digest information that contributes to Arkema SA's financial success or failures. It also enables traders to predict the movement of Arkema Pink Sheet. The fundamental analysis module provides a way to measure Arkema SA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Arkema SA pink sheet.
Arkema |
Arkema SA ADR Company Current Valuation Analysis
Arkema SA's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Arkema SA Current Valuation | 8.73 B |
Most of Arkema SA's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Arkema SA ADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Arkema SA ADR has a Current Valuation of 8.73 B. This is 23.51% lower than that of the Basic Materials sector and 71.67% lower than that of the Specialty Chemicals industry. The current valuation for all United States stocks is 47.5% higher than that of the company.
Arkema SA ADR Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Arkema SA's current stock value. Our valuation model uses many indicators to compare Arkema SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Arkema SA competition to find correlations between indicators driving Arkema SA's intrinsic value. More Info.Arkema SA ADR is number one stock in return on equity category among its peers. It is rated fourth in return on asset category among its peers reporting about 0.22 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Arkema SA ADR is roughly 4.59 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Arkema SA by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Arkema SA's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Arkema Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Arkema SA's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Arkema SA could also be used in its relative valuation, which is a method of valuing Arkema SA by comparing valuation metrics of similar companies.Arkema SA is currently under evaluation in current valuation category among its peers.
Arkema Fundamentals
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0333 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 8.73 B | |||
| Shares Outstanding | 74.81 M | |||
| Shares Owned By Institutions | 0.03 % | |||
| Price To Earning | 18.63 X | |||
| Price To Book | 0.82 X | |||
| Price To Sales | 0.58 X | |||
| Revenue | 9.52 B | |||
| Gross Profit | 2.14 B | |||
| EBITDA | 2.54 B | |||
| Net Income | 1.31 B | |||
| Cash And Equivalents | 1.34 B | |||
| Cash Per Share | 18.14 X | |||
| Total Debt | 2.56 B | |||
| Debt To Equity | 0.47 % | |||
| Current Ratio | 1.90 X | |||
| Book Value Per Share | 105.12 X | |||
| Cash Flow From Operations | 915 M | |||
| Earnings Per Share | 15.24 X | |||
| Price To Earnings To Growth | 0.77 X | |||
| Target Price | 110.28 | |||
| Number Of Employees | 20.2 K | |||
| Beta | 1.27 | |||
| Market Capitalization | 7.51 B | |||
| Total Asset | 12.3 B | |||
| Retained Earnings | 1.21 B | |||
| Working Capital | 1.92 B | |||
| Current Asset | 3.4 B | |||
| Current Liabilities | 1.48 B | |||
| Z Score | 1.2 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 2.57 % | |||
| Net Asset | 12.3 B | |||
| Last Dividend Paid | 3.0 |
About Arkema SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Arkema SA ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Arkema SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Arkema SA ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. Arkema S.A. was incorporated in 2003 and is headquartered in Colombes, France. Arkema ADR operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 19441 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Arkema Pink Sheet Analysis
When running Arkema SA's price analysis, check to measure Arkema SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arkema SA is operating at the current time. Most of Arkema SA's value examination focuses on studying past and present price action to predict the probability of Arkema SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arkema SA's price. Additionally, you may evaluate how the addition of Arkema SA to your portfolios can decrease your overall portfolio volatility.